Monthly Archives August 2019

Click here to read the supplier notification regarding the short-term supply issue with the above mentioned product. PHARMAC have advise they understand that stock of Ritalin SR Tab 20 mg 100 will be available again mid-September 2019. ProPharma / PWR have no stock available. We wish to advise that we have sufficient stock of the alternative:- Rubifen SR Tab 20…

This is a follow on from our article of 14 May 2019 & 15 April 2019. Additional information will be bolded in italics. The following information has been provided to us:- Furosemide [frusemide] 40 mg tablets (Diurin 40) supply issue – removal of stat and short expiry date. Mylan is discontinuing supply of its Diurin 40 tablets – furosemide tab…

As advised via PHARMAC proposal of 29 January 2019 and the notification of PHARMAC decision of 28 March 2019 there is to be a change in the listing and future sole supply of Flecainide Capsules. New listing from 1 July 2019 Flecainide-Teva Cap 100 mg 90                         Pharmacode 2567113                  Schedule price $39.51 Flecainide-Teva Cap 200 mg 90                        …

Click here to read the notification of 23 August 2019 from Mylan. Please take special note of the new listings, product changes and discontinued products. Accarb Tab 100 mg 90 will be available from ProPharma / PWR as soon as stock is released by Mylan. Carbidopa and Levodopa Extended Release Tab 50 mg / 200 mg 100 will be available…

Click here to read the original notifications for Amiodarone Hydrochloride Injection 150 mg, Flecainide Tablets 50 mg and Clizapril Tablets 2.5 mg & 5 mg All of these products will have DUAL listings in the Pharmaceutical Schedule & where applicable HML from 1 September 2019 until 31 January 2020. We ask that you continue to order the incumbent brand(s) to…

Click here to read the notification of 9 August 2019 from Mylan. Please take special note of the new listings, price changes, alternative listings and Pharmacode changes. Zapril Tab 2.5mg and 5 mg will be listed from 1 September 2019 and will be part of a 5 month dual listing with Cilazapril-Apo until 1 February 2020 when the Sole Supply…

Click here to read the notification from Juno Pharmaceuticals NZ Ltd the sponsor of the above product in New Zealand and Australia. Section 29 criteria no longer apply and as per Pharmaceutical Schedule Update August 2019. We thank you in anticipation of your ongoing support.  

12
Close